MetLife Investment Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.4M | Buy |
|
|||||
|
2023
Q3 | $772K | Hold |
|
|||||
|
2023
Q2 | $567K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $163K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $96.7K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $142K | Buy |
|
|||||
|
2020
Q4 | $87.8K | Sell |
|
|||||
|
2020
Q3 | $155K | Sell |
|
|||||
|
2020
Q2 | $122K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $128K | Sell |
|
|||||
|
2019
Q2 | $300K | Buy |
|
|||||
|
2019
Q1 | $374K | Hold |
|
|||||
|
2018
Q4 | $222K | Hold |
|
|||||
|
2018
Q3 | $312K | Hold |
|
|||||
|
2018
Q2 | $378K | Buy |
|